Articles: treatment.

• Latest
• Best
• Search…

• J. Thorac. Cardiovasc. Surg. · May 2024

  Editorial

  Author Reply to Commentary: Surgical Treatment for Atrial Fibrillation: When It Comes to Atrial Fibrillation It Is Not the Great Evidence, It Is the Surgeon.

  no abstract available

  expand abstract… or not…

• Resuscitation · May 2024

  Editorial

  Cardiac arrest: Treatment is prevention?

  no abstract available

  expand abstract… or not…

• Ann. Intern. Med. · May 2024

  Annals Video Summary - Newer Pharmacologic Treatments in Adults With Type 2 Diabetes.

  no abstract available

  read on… or not…

• CMAJ · Apr 2024

  The journey of a patient with lung cancer from symptoms to treatment.

  no abstract available

  expand abstract… or not…

• Lancet · Apr 2024

  Randomized Controlled Trial Multicenter Study

  3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.

  PHERGain was designed to assess the feasibility, safety, and efficacy of a chemotherapy-free treatment based on a dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and pertuzumab in patients with HER2-positive early breast cancer (EBC). It used an 18fluorine-fluorodeoxyglucose-PET-based, pathological complete response (pCR)-adapted strategy. ⋯ F Hoffmann-La Roche.

  read on… or not…